MITF and renal cell adenocarcinoma: These are tubulocystic RCC (38), acquired cystic disease-associated RCC (39), clear cell (tubulo) papillary RCC (40), microphthalmia transcription factor family (MiTF) translocation RCC (41) and hereditary leiomyomatosis RCC syndrome-associated RCC (42).